A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung

NCT05470595 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Large Cell Neuroendocrine Carcinoma of the Lung

Interventions

DRUG: Atezolizumab

Sponsor

Technische Universität Dresden

Collaborators

[object Object]